RAFAEL HOLDINGS, INC. Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge
RAFAEL HOLDINGS, INC. (RFL) reported Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge of -$166.00 thousand for the 3-month period ending 2023-10-31, per its 10-Q filed 2023-12-14.
Discontinued › Income Statement › Other Income
us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1 · last filed 2023-12-14
- RAFAEL HOLDINGS, INC. change in unrealized gain (loss) on hedged item in fair value hedge for the quarter ending 2023-10-31 was -$166.00K.
- RAFAEL HOLDINGS, INC. change in unrealized gain (loss) on hedged item in fair value hedge for the quarter ending 2022-10-31 was -$127.00K.
| Period end | Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge 3 month |
|---|---|
| 2023-10-31 | -$166.00K 10-Q · filed 2023-12-14 |
| 2022-10-31 | -$127.00K 10-Q · filed 2023-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |